Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. / Vilsbøll, Tina; Brock, Birgitte; Perrild, Hans; Levin, K; Lervang, Hans-Henrik; Kølendorf, Klaus Erik; Krarup, T; Schmitz, Ole; Zdravkovic, M; Le Thi Thanh, Xuan; Madsbad, S.

I: Diabetic Medicine, Bind 25, Nr. 2, 01.02.2008, s. 152-6.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Vilsbøll, T, Brock, B, Perrild, H, Levin, K, Lervang, H-H, Kølendorf, KE, Krarup, T, Schmitz, O, Zdravkovic, M, Le Thi Thanh, X & Madsbad, S 2008, 'Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus', Diabetic Medicine, bind 25, nr. 2, s. 152-6. https://doi.org/10.1111/j.1464-5491.2007.02333.x

APA

Vilsbøll, T., Brock, B., Perrild, H., Levin, K., Lervang, H-H., Kølendorf, K. E., Krarup, T., Schmitz, O., Zdravkovic, M., Le Thi Thanh, X., & Madsbad, S. (2008). Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabetic Medicine, 25(2), 152-6. https://doi.org/10.1111/j.1464-5491.2007.02333.x

Vancouver

Vilsbøll T, Brock B, Perrild H, Levin K, Lervang H-H, Kølendorf KE o.a. Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. Diabetic Medicine. 2008 feb. 1;25(2):152-6. https://doi.org/10.1111/j.1464-5491.2007.02333.x

Author

Vilsbøll, Tina ; Brock, Birgitte ; Perrild, Hans ; Levin, K ; Lervang, Hans-Henrik ; Kølendorf, Klaus Erik ; Krarup, T ; Schmitz, Ole ; Zdravkovic, M ; Le Thi Thanh, Xuan ; Madsbad, S. / Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus. I: Diabetic Medicine. 2008 ; Bind 25, Nr. 2. s. 152-6.

Bibtex

@article{3ea0c686e19e474cacaecb505fb53bee,
title = "Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus",
abstract = "To assess the effect of liraglutide, a once-daily human glucagon-like peptide-1 analogue on pancreatic B-cell function. methods: Patients with Type 2 diabetes (n = 39) were randomized to treatment with 0.65, 1.25 or 1.9 mg/day liraglutide or placebo for 14 weeks. First- and second-phase insulin release were measured by means of the insulin-modified frequently sampled intravenous glucose tolerance test. Arginine-stimulated insulin secretion was measured during a hyperglycaemic clamp (20 mmol/l). Glucose effectiveness and insulin sensitivity were estimated by means of the insulin-modified frequently sampled intravenous glucose tolerance test.",
author = "Tina Vilsb{\o}ll and Birgitte Brock and Hans Perrild and K Levin and Hans-Henrik Lervang and K{\o}lendorf, {Klaus Erik} and T Krarup and Ole Schmitz and M Zdravkovic and {Le Thi Thanh}, Xuan and S Madsbad",
year = "2008",
month = feb,
day = "1",
doi = "http://dx.doi.org/10.1111/j.1464-5491.2007.02333.x",
language = "English",
volume = "25",
pages = "152--6",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

AU - Vilsbøll, Tina

AU - Brock, Birgitte

AU - Perrild, Hans

AU - Levin, K

AU - Lervang, Hans-Henrik

AU - Kølendorf, Klaus Erik

AU - Krarup, T

AU - Schmitz, Ole

AU - Zdravkovic, M

AU - Le Thi Thanh, Xuan

AU - Madsbad, S

PY - 2008/2/1

Y1 - 2008/2/1

N2 - To assess the effect of liraglutide, a once-daily human glucagon-like peptide-1 analogue on pancreatic B-cell function. methods: Patients with Type 2 diabetes (n = 39) were randomized to treatment with 0.65, 1.25 or 1.9 mg/day liraglutide or placebo for 14 weeks. First- and second-phase insulin release were measured by means of the insulin-modified frequently sampled intravenous glucose tolerance test. Arginine-stimulated insulin secretion was measured during a hyperglycaemic clamp (20 mmol/l). Glucose effectiveness and insulin sensitivity were estimated by means of the insulin-modified frequently sampled intravenous glucose tolerance test.

AB - To assess the effect of liraglutide, a once-daily human glucagon-like peptide-1 analogue on pancreatic B-cell function. methods: Patients with Type 2 diabetes (n = 39) were randomized to treatment with 0.65, 1.25 or 1.9 mg/day liraglutide or placebo for 14 weeks. First- and second-phase insulin release were measured by means of the insulin-modified frequently sampled intravenous glucose tolerance test. Arginine-stimulated insulin secretion was measured during a hyperglycaemic clamp (20 mmol/l). Glucose effectiveness and insulin sensitivity were estimated by means of the insulin-modified frequently sampled intravenous glucose tolerance test.

U2 - http://dx.doi.org/10.1111/j.1464-5491.2007.02333.x

DO - http://dx.doi.org/10.1111/j.1464-5491.2007.02333.x

M3 - Journal article

VL - 25

SP - 152

EP - 156

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 2

ER -

ID: 34070207